Yondelis (trabectedin) 1 mg IV JANSSEN Belgium
Article:
J-5
In Stock
Indications
- In combination with pegylated liposomal doxorubicin hydrochloride, Yondelis is indicated for the treatment of platinum-sensitive recurrent ovarian cancer.
- Yondelis is indicated for the treatment of patients with advanced soft tissue sarcoma who have failed or are unsuitable for anthracyclines and ifosfamide. Efficiency is shown mainly in patients with liposarcoma and leimiosarcoma.
- 1150 ct
- iondelis, yon, ion, yondalis
-
Commercial name:Yondelis
-
Сhemical name:Trabectedin
-
Dosage:1 mg
-
Release form:Ampoule
No reviews yet